The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol

Summary

The primary objective is to provide access to eculizumab for PNH patient pending commercial availability.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications